Cancer Radioimmunotherapy
- 11 March 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Immunotherapy
- Vol. 3 (3), 349-370
- https://doi.org/10.2217/imt.10.114
Abstract
Targeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field of research spanning nearly 50 years, evolving with advancing technologies in molecular biology and chemi...Funding Information
- NIH grants (P01 CA103985, R01 CA107088)
This publication has 249 references indexed in Scilit:
- Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancerCancer, 2010
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastomaJournal of Neuro-Oncology, 2009
- Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumabNuclear Medicine and Biology, 2009
- Therapeutic efficacy of 177Lu‐CHX‐A″‐DTPA‐hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapyThe Prostate, 2008
- Use of antibodies and immunoconjugates for the therapy of more accessible cancersAdvanced Drug Delivery Reviews, 2008
- Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applicationsAdvanced Drug Delivery Reviews, 2008
- Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome CarriersBioconjugate Chemistry, 2007
- Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORFEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspectsNuclear Medicine and Biology, 2007
- Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodiesNuclear Medicine and Biology, 2007